• Patients with newly diagnosed breast cancer and

• treatment

• Breast cancer survivor

• Breast cancer screening

• High-Risk Breast Cancer Family Members

Our Service is built upon the philosophy of “Once a patient of our hospital, always a patient of our hospital” and a patient-centered approach. We also provide continuous support throughout the entire breast cancer journey. In 2016, we treated 847 newly diagnosed breast cancer patients, representing 7.23% of all new breast cancer cases in Taiwan. The nursing team includes Screening nurses, Patient Advocacy Service nurses, Care managers,Nurse Practitioners, PICC nurses,Aadvanced Practice nurses, Survivorship nurses, Palliative shared-care nurses, and Home-based palliative care managers. Innovative initiatives include the establishment of breast cancer screening nurse training, PAS service pathways, Advanced Practice Nurse training programs, and Taiwan’s first Breast Cancer Navigator Program. To enhance care quality, we revised breast cancer care management processes and nursing assessment information system. We also established Taiwan’s first Breast Cancer Survivorship Clinic, providing long-term follow-up care, recurrence surveillance and chronic disease managemen. Standardized assessments include pain, functional status, nutritional status, and psychosocial distress screening. Through proactive monitoring and coordinated interventions, patients receive comprehensive support throughout treatment and survivorship. Evidence shows that effective care management improves treatment adherence, completion rates, symptom control, patient satisfaction, and survival outcomes.

• Once a patient of our hospital, always a patient of our hospital

• Comprehensive Breast Cancer Care Across the

• Continuum

• Screening to survivorship and palliative care

• Patient Advocacy Service (PAS) Nurse Program

• Advanced Breast Cancer Nurse Training

• Survivorship Clinic for long-term follow-up

• Four standardized assessments for complication

• monitoring and supportive care

• Integrated Medical–Nursing Patient Information

• System

• Comprehensive Education and Training Program for

• Specialized Nursing Roles

•847 newly diagnosed breast cancer patients,

representing 7.23% of all new breast cancer cases in

Taiwan200 beds.

•The breast cancer long-term follow-up clinic has

more than 10,000 visits each year.

• Program Achievements (2018)

• Screening-positive follow-up rate: 93.6%

• Treatment completion rate: 97.05%

• Loss-to-follow-up rate reduced from 0.33% to 0.07%

• Treatment adherence: Surgery 99.52%,

• Chemotherapy 93.16%, Radiotherapy 96.64%

• Patient satisfaction:92.3%

• Healthcare team satisfaction: 4.71/5

• Time to diagnosis reduced from 8.18 to 7.27 days

• after PAS implementation

• Postoperative lymphedema rate: 6.88% (vs. 21.4%

• reported internationally)

• Only 1.97% of survivorship clinic patients requested

• follow-up with their original physician

• The 5-year treatment dropout rate for breast cancer

• patients was 13.9%, compared with 21% reported in

• international literature.

•Compliance with patient identification procedures

achieved 100% accuracy and implementation.

•Patient education on fall prevention and

environmental safety inspection compliance reached

100%.

•Daily pre-clinic equipment inspections achieved a

100% completion rate.

•A comprehensive risk management system was

maintained, encompassing hazardous materials

management, emergency preparedness, fire safety,

medical equipment maintenance, utility management,

security systems, medical gas systems, air-

conditioning equipment, and building infrastructure

safety. Regular inspections, maintenance, and staff

training contributed to the successful maintenance

of Joint Commission International (JCI) accreditation

for 12 consecutive years.

•Completeness of advanced practice nurse

documentation reached 98.9%, compliance with

guideline-based physical assessments reached

99.4%, completeness of diagnostic and procedural

records reached 100%, accuracy of follow-up

scheduling records reached 100%, completeness of

abnormal result management reached 99.4%, and

medication documentation completeness reached

99.4%.

•Each advanced practice nurse completed at least 100

breast assessments annually, with imaging

correlation and physician verification.

•The incidence of postop – related lymphedema was

6.88%, lower than the 21.4% reported in

international literature.

•The incidence of severe radiation-induced dermatitis

was only 1%.

• In 2018, patient satisfaction reached 92.3%, while

healthcare team satisfaction achieved 4.71 out of 5.

•In 2011, it was honored with the Gold Magnet Award

for Excellence in Nursing Practice Environment,

presented by the Taiwan Nurses Association,

recognizing its positive and supportive nursing

workplace.

•In 2016, the breast cancer program received first

place among regional hospitals in the National Breast

Cancer Screening and Treatment Quality

Improvement Program, awarded by Taiwan’s Health

Promotion Administration. This award recognized

exceptional performance in ensuring timely follow-up

and treatment for patients with abnormal breast

cancer screening results. Further recognition was

received in 2017 and 2018 through the Taipei City

Cancer Prevention Best Partnership Award and the

Cancer Prevention Progress Award. We also received

the Cancer Prevention Angel Award for achieving a

follow-up completion rate exceeding 90% among

patients with positive cancer screening results.

•In 2011, its care management achievements

were featured in a special interview by

CommonWealth Magazine.

•In 2016, the multidisciplinary breast cancer team

published Understanding Breast Cancer: A

Comprehensive Guide through Common Health

Magazine, providing evidence-based information and

education to patients, families, and healthcare

professionals.

• KFSYSCC has developed an integrated breast cancer care model incorporating multidisciplinary care coordination and value-based reimbursement strategies. This innovative approach was recognized internationally and selected as a Harvard Business School teaching case, highlighting its contribution to healthcare management and value-based cancer care.

• KFSYSCC has continuously maintained Joint Commission International (JCI) accreditation, demonstrating excellence in patient safety that support high-quality breast cancer care.

• KFSYSCC has also served as a benchmark institution for healthcare organizations and academic groups worldwide, including Austria, Vietnam, Thailand, Japan, Hong Kong, and mainland China.

• As a leading cancer center in Asia, KFSYSCC actively contributes to cancer research, genomic medicine, clinical trials, and quality improvement initiatives. Its scientific achievements have been published in international peer-reviewed journals and recognized by global research databases.

• KFSYSCC maintains long-term collaborations with leading cancer institutions in the United States and across Asia, supporting international research, professional training, and educational exchange programs.

• In 2018, the 5-year survival rate for breast cancer reached 93%, exceeding the 91% reported in the American Cancer Society’s Breast Cancer Facts & Figures 2017–2018. Survival outcomes were also higher than those reported in Japan and Australia (90%) and South Korea.

KFSYSCC has gained international recognition for its innovative, patient-centered, and value-based care model. The Center’s integrated breast cancer care program, combined with a bundled payment and pay-for-performance reimbursement system, was selected as a Harvard Business School teaching case entitled “Koo Foundation Sun Yat-Sen Cancer Center: Breast Cancer Care in Taiwan.” The case has been recognized as an important example of healthcare management, quality improvement, and value-based cancer care. As Taiwan’s first specialty cancer hospital, KFSYSCC pioneered a comprehensive breast cancer care model that spans the entire continuum of care. The Integrated breast Cancer Clinic Service incorporates multidisciplinary team care, patient navigation services, case management, survivorship care, and palliative care, providing coordinated and seamless support from screening and diagnosis through treatment and long-term follow-up. This model has subsequently influenced care development across other cancer specialties in Taiwan.